Major investment strengthens pharmaceutical supply chain resilience and advances green manufacturing practices in North America.
Major investment strengthens pharmaceutical supply chain resilience and advances green manufacturing practices in North America.
Sustained-release axitinib hydrogel shows promising efficacy and safety in wet age-related macular degeneration and diabetic retinopathy, setting foundation …
Commercial partnership targets scalability, 24/7 PET imaging product access, and future expansion for next-gen cancer diagnostics.
Clinical trial results underscore safety and diagnostic accuracy for radiopharmaceutical imaging; Clarity pursues regulatory filings and wider manufacturing …
Leading biopharma companies are leveraging digital technologies and manufacturing expansions to enhance drug development and patient care.
Investments in next-generation manufacturing facilities are unlocking scale, speed, and quality for cell and gene therapies, propelling North …
Advanced manufacturing technologies are transforming biopharma production lines, driving efficiency, quality, and scalability to meet growing global demand.
Manufacturing breakthroughs are set to transform cell therapy production, paving the way for faster trials and wider patient …
Already a subscriber? Log in